Invention Grant
- Patent Title: 4-isopropyl-6-methoxyphenyl glucitol compound
- Patent Title (中): 4-异丙基-6-甲氧基苯基葡糖醇化合物
-
Application No.: US13817666Application Date: 2011-08-19
-
Publication No.: US09161945B2Publication Date: 2015-10-20
- Inventor: Hiroyuki Kakinuma , Yohei Kobashi , Tomomichi Chonan , Fumiyasu Shiozawa , Yuki Iwata , Takahiro Oi , Kenichi Kawabe
- Applicant: Hiroyuki Kakinuma , Yohei Kobashi , Tomomichi Chonan , Fumiyasu Shiozawa , Yuki Iwata , Takahiro Oi , Kenichi Kawabe
- Applicant Address: JP Tokyo
- Assignee: TAISHO PHARMACEUTICAL CO., LTD.
- Current Assignee: TAISHO PHARMACEUTICAL CO., LTD.
- Current Assignee Address: JP Tokyo
- Agency: Sughrue Mion, PLLC
- Priority: JP2010-184866 20100820
- International Application: PCT/JP2011/068738 WO 20110819
- International Announcement: WO2012/023600 WO 20120223
- Main IPC: C08B37/00
- IPC: C08B37/00 ; C07H5/04 ; C07H5/06 ; A61K31/7034 ; A61K31/351 ; C07D309/10
Abstract:
A compound, which inhibits SGLT1 (sodium-dependent glucose transporter 1) activity to suppress absorption of glucose or the like, thereby suppressing abnormal glucose tolerance or postprandial hyperglycemia in diabetes, is provided. Specifically, a 4-isopropyl-6-methoxyphenyl glucitol compound represented by the following formula (I), or a pharmaceutically acceptable salt thereof, is provided:
Public/Granted literature
- US20130165645A1 4-ISOPROPYL-6-METHOXYPHENYL GLUCITOL COMPOUND Public/Granted day:2013-06-27
Information query
